HOME >> BIOLOGY >> NEWS
Imagine no restrictions on fossil-fuel usage and no global warming

ORLANDO, Fla., April 9, 2002 - Researchers at the U.S. Department of Energy's Los Alamos National Laboratory are studying a simple, cost effective method for extracting carbon dioxide directly from the air - which could allow sustained use of fossil fuels while avoiding potential global climate change.

The method would allow researchers to harvest carbon dioxide from the air, reducing buildup of the so-called "greenhouse gas" in the atmosphere and allowing it to be converted into fuel. A Los Alamos-led research team today presented the topic at the 223rd annual meeting of the American Chemical Society in Orlando, Fla.

"Fossil fuel supplies are plentiful, and what will limit the usage of fossil fuels is the potential climatic and ecosystem changes you may see as a result of rising CO2 levels in the atmosphere," said Los Alamos researcher Manvendra Dubey. "If you can capture atmospheric carbon dioxide, then you limit the environmental impact of fossil fuels and you can continue to use them. We have come up with a way to capture and sequester the carbon dioxide that we are putting in the atmosphere. Our approach is particularly well suited to capturing CO2 from numerous small sources such as automobiles that are largely being ignored."

While many scientists are working on capturing or sequestering carbon, Dubey and his colleagues' method differs because it works on a dilute stream of CO2 in the atmosphere as opposed to capturing more concentrated forms found in power plant exhausts. The method uses ordinary air with its average carbon dioxide concentration of about 370 parts per million.

It utilizes the wind and natural atmospheric mixing to transport CO2 to a removal site, and it is the only means available to capture CO2 generated from transportation sources and small, dispersed sources that account for nearly half of all carbon dioxide emissions.

The air is passed over an extraction agent, for example a solution of quicklime, the active
'"/>

Contact: James Rickman
elvis@lanl.gov
505-665-9203
DOE/Los Alamos National Laboratory
9-Apr-2002


Page: 1 2 3

Related biology news :

1. Lake restrictions make lakeshore property more valuable
2. Officials delay trade restrictions on Caspian Sea caviar
3. BioMed Central to free scientists and clinical researchers from copyright restrictions
4. Eating transgenic sausages
5. Poplar DNA code cracked -- a step in combating global warming?
6. Do genes respond to global warming?
7. Fossils reveal direct link between global warming and genetic diversity in wildlife
8. Technology already exists to stabilize global warming
9. NASA scientists get global fix on food, wood & fiber use
10. New version of premier global climate model released
11. Trapping carbon in soil key for protecting global food security, dealing with climate change

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Imagine restrictions fossil fuel usage and global warming

(Date:10/18/2014)... suspected genetic conditions, a certain type of exome sequencing ... than traditional molecular diagnostic methods, according to a study ... released to coincide with the American Society of Human ... protein­coding region of the genome (the complete set of ... organism), has been rapidly applied in research settings and ...
(Date:10/17/2014)... release is available in German . ... of sperms every day in order to reproduce? And why ... the topic of the latest issue of the research journal ... The evolutionary biologist Steven Ramm from Bielefeld University Bielefeld has ... is not unusual for a female to copulate with several ...
(Date:10/17/2014)... To date, antidotes ... doctors are often limited to supportive therapy such as induced ... of drugs involved. So what can be done if a ... professor Jean-Christophe Leroux from the Institute of Pharmaceutical Sciences at ... "The task was to develop an agent that could eliminate ...
Breaking Biology News(10 mins):Study examines type of exome sequencing and molecular diagnostic yield 2Study examines type of exome sequencing and molecular diagnostic yield 3Sperm wars 2Emergency aid for overdoses 2Emergency aid for overdoses 3
(Date:10/22/2014)... Oct. 22, 2014   Synthetic Biologics, Inc. ... therapies for serious infections and diseases, announced today that ... Notice of Allowance for a composition of matter patent ... difficile program, SYN-004. This is Synthetic Biologics, first ... U.S. and adds to the Company,s extensive C. ...
(Date:10/22/2014)... and HONG KONG , Oct. ... disease therapeutics enterprise, announced today that rare disease expert ... as vice president, research. Dr. McKew brings more than ... leadership positions at the National Institutes of Health, Wyeth ... by Wyeth). Dr. McKew will lead aTyr,s efforts to expand ...
(Date:10/20/2014)... 20, 2014 Asterias Biotherapeutics, Inc. (NYSE ... signed a Notice of Grant Award (NGA) with ... October 1, 2014.  The NGA provides for the ... release of additional grant funds pursuant to the ... clinical development of Asterias, product, AST-OPC1. The grant ...
(Date:10/20/2014)... BOSTON , Oct. 20, 2014 ... commercialization company tackling big healthcare problems, announced today ... investment round, with participation from Invesco Perpetual, a ... be used to drive PureTech,s existing pipeline forward ... technologies. "PureTech has the scientific creativity to really ...
Breaking Biology Technology:Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 2PureTech Announces Expansion with Oversubscribed $55M Funding Round 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 5PureTech Announces Expansion with Oversubscribed $55M Funding Round 6
Cached News: